España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Abbott Laboratories
ABT
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$128.81
0.95
0.74%
At close: -
$128.50
-0.31
-0.24%
After Hours: 6:03 PM EDT
Get Report
Comment
Abbott Laboratories (ABT) Forecast
News
Earnings
Abbott Laboratories (ABT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Abbott Laboratories (NYSE:ABT) Stock
Abbott Laboratories Stock (NYSE: ABT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 28, 2025
9 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, January 27, 2025
This Is What Whales Are Betting On Abbott Laboratories
Benzinga Insights
Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? 'Something May Be Wrong Here'
Avi Kapoor
Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
Barclays Maintains Overweight on Abbott Labor...
Benzinga Newsdesk
Friday, January 24, 2025
Market Whales and Their Recent Bets on ABT Options
Benzinga Insights
Thursday, January 23, 2025
Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
Why Is Abbott Stock Trading Higher On Thursday?
Vandana Singh
Congressional Trading Report: Rep. Thomas Kean Bought Over $1K In Abbott Laboratories Stock
Benzinga Insights
RBC Capital Reiterates Outperform on Abbott L...
Benzinga Newsdesk
Abbott shares are trading higher after multip...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on Abbott La...
Benzinga Newsdesk
Stifel Maintains Buy on Abbott Laboratories, ...
Benzinga Newsdesk
UBS Maintains Buy on Abbott Laboratories, Rai...
Benzinga Newsdesk
US Stock Futures Trade Mixed After Skirting Record Highs In Last Session: GE Aerospace, American Airlines, Union Pacific In Focus
Rishabh Mishra
S&P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In 'Fear' Zone
Avi Kapoor
Wednesday, January 22, 2025
S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run
Piero Cingari
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
Avi Kapoor
Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What's Driving Markets Wednesday?
Piero Cingari
Abbott Exec Says Co Expects To See An Unfavor...
Benzinga Newsdesk
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall
Vandana Singh
Abbott Laboratories shares are trading lower ...
Benzinga Newsdesk
Abbott Laboratories Expects 2025 Adjusted EPS...
Benzinga Newsdesk
Abbott Laboratories Expects Q1 2025 Adjusted ...
Benzinga Newsdesk
Abbott Laboratories Q4 2024 Adj. EPS $1.34, I...
Benzinga Newsdesk
US Stocks Likely To Open Higher As Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch
Rounak Jain
Earnings Scheduled For January 22, 2025
Benzinga Insights
Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Avi Kapoor
Netflix, Procter & Gamble And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor
Tuesday, January 21, 2025
RBC Capital Reiterates Outperform on Abbott L...
Benzinga Newsdesk
Wednesday, January 15, 2025
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
Maureen Meehan
Tuesday, January 14, 2025
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Wednesday, January 08, 2025
8 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Tuesday, January 07, 2025
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Nabaparna Bhattacharya
Monday, December 30, 2024
How Is The Market Feeling About Abbott Laboratories?
Benzinga Insights
Monday, December 23, 2024
Abbott And DexCom Settle Global Patent Disput...
Benzinga Newsdesk
Tuesday, December 17, 2024
Alberta Government Adds Abbott Laboratories' ...
Benzinga Newsdesk
Abbott Reports Completion Of In-human Leadles...
Benzinga Newsdesk
Friday, December 13, 2024
Abbott Increases Quarterly Dividend From $0.5...
Benzinga Newsdesk
Wednesday, December 11, 2024
Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them
Avi Kapoor
Friday, December 06, 2024
Peering Into Abbott Laboratories's Recent Short Interest
Benzinga Insights
Monday, November 25, 2024
Abbott Tests New Balloon-Expandable TAVI Syst...
Benzinga Newsdesk
Wednesday, November 20, 2024
Insulet Announces Omnipod 5 System Is Now Com...
Benzinga Newsdesk
Monday, November 18, 2024
Abbott's Amplatzer Amulet Device Demonstrates...
Benzinga Newsdesk
Saturday, November 16, 2024
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Juan Spínelli
Tuesday, November 05, 2024
Analyst Ratings For Abbott Laboratories
Benzinga Insights
Barclays Maintains Overweight on Abbott Labor...
Benzinga Newsdesk
Monday, November 04, 2024
Abbott's Esprit BTK System Shows Sustained Tw...
Benzinga Newsdesk
Friday, November 01, 2024
Abbott Laboratories shares are trading higher...
Benzinga Newsdesk
Reported October 31: Abbott Laboratories And ...
Benzinga Newsdesk
Show More